1. OP0291 Romosozumab Administration is Associated with Significant Improvements in Lumbar Spine and Hip Volumetric Bone Mineral Density and Content Compared with Teriparatide. (10th June 2014) Authors: Genant, H.; Bolognese, M.; Mautalen, C.; Brown, J.; Recknor, C.; Goemaere, S.; Engelke, K.; Yang, Y.-C.; Austin, M.; Grauer, A.; Libanati, C. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0037 Denosumab discontinuation and associated fracture incidence: Analysis from the freedom trial. (23rd January 2014) Authors: Törring, O.; Brown, J.; Jensen, J.-E.B.; Gilchrist, N.; Recknor, C.; Roux, C.; Austin, M.; Wang, A.; Grauer, A.; Ho, P.-R.; Wagman, R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗